These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 30358878)

  • 1. The impact of diabetes mellitus on the clinical phenotype of hypertrophic cardiomyopathy.
    Wasserstrum Y; Barriales-Villa R; Fernández-Fernández X; Adler Y; Lotan D; Peled Y; Klempfner R; Kuperstein R; Shlomo N; Sabbag A; Freimark D; Monserrat L; Arad M
    Eur Heart J; 2019 Jun; 40(21):1671-1677. PubMed ID: 30358878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of type 2 diabetes mellitus on mid-term mortality for hypertrophic cardiomyopathy patients who underwent septal myectomy.
    Wang S; Cui H; Ji K; Song C; Ren C; Guo H; Zhu C; Wang S; Lai Y
    Cardiovasc Diabetol; 2020 May; 19(1):64. PubMed ID: 32404127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy.
    Olivotto I; Maron BJ; Tomberli B; Appelbaum E; Salton C; Haas TS; Gibson CM; Nistri S; Servettini E; Chan RH; Udelson JE; Lesser JR; Cecchi F; Manning WJ; Maron MS
    J Am Coll Cardiol; 2013 Jul; 62(5):449-57. PubMed ID: 23643593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of diabetes mellitus on the outcomes of subjects with hypertrophic cardiomyopathy: A nationwide cohort study.
    Lee HJ; Kim HK; Kim BS; Han KD; Rhee TM; Park JB; Lee H; Lee SP; Kim YJ
    Diabetes Res Clin Pract; 2022 Apr; 186():109838. PubMed ID: 35314254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry.
    Lopes LR; Losi MA; Sheikh N; Laroche C; Charron P; Gimeno J; Kaski JP; Maggioni AP; Tavazzi L; Arbustini E; Brito D; Celutkiene J; Hagege A; Linhart A; Mogensen J; Garcia-Pinilla JM; Ripoll-Vera T; Seggewiss H; Villacorta E; Caforio A; Elliott PM;
    Eur Heart J Qual Care Clin Outcomes; 2022 Dec; 9(1):42-53. PubMed ID: 35138368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.
    Lu DY; Pozios I; Haileselassie B; Ventoulis I; Liu H; Sorensen LL; Canepa M; Phillip S; Abraham MR; Abraham TP
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy.
    Olivotto I; Maron MS; Adabag AS; Casey SA; Vargiu D; Link MS; Udelson JE; Cecchi F; Maron BJ
    J Am Coll Cardiol; 2005 Aug; 46(3):480-7. PubMed ID: 16053962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and prognostic impact of chronotropic incompetence in patients with hypertrophic cardiomyopathy.
    Magri D; Agostoni P; Sinagra G; Re F; Correale M; Limongelli G; Zachara E; Mastromarino V; Santolamazza C; Casenghi M; Pacileo G; Valente F; Morosin M; Musumeci B; Pagannone E; Maruotti A; Uguccioni M; Volpe M; Autore C
    Int J Cardiol; 2018 Nov; 271():125-131. PubMed ID: 30087038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes in Patients With Hypertrophic Cardiomyopathy and Left Ventricular Systolic Dysfunction.
    Rowin EJ; Maron BJ; Carrick RT; Patel PP; Koethe B; Wells S; Maron MS
    J Am Coll Cardiol; 2020 Jun; 75(24):3033-3043. PubMed ID: 32553256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk stratification and outcome of patients with hypertrophic cardiomyopathy >=60 years of age.
    Maron BJ; Rowin EJ; Casey SA; Haas TS; Chan RH; Udelson JE; Garberich RF; Lesser JR; Appelbaum E; Manning WJ; Maron MS
    Circulation; 2013 Feb; 127(5):585-93. PubMed ID: 23275385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, Clinical Characteristics, and Long-term Outcome of the Dilated Phase of Hypertrophic Cardiomyopathy.
    Aizawa Y; Tanimoto Y; Hirata Y; Fujisawa T; Fukuoka R; Nakajima K; Katsumata Y; Nishiyama T; Kimura T; Yuasa S; Kohno T; Kohsaka S; Murata M; Maekawa Y; Furukawa Y; Takatsuki S; Fukuda K
    Keio J Med; 2019 Dec; 68(4):87-94. PubMed ID: 30606897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of mitral regurgitation in patients with hypertrophic cardiomyopathy using aortic and pulmonary flow data: impacts of left ventricular outflow tract obstruction and different left ventricular segmentation methods.
    Śpiewak M; Kłopotowski M; Gawor M; Kubik A; Kowalik E; Miłosz-Wieczorek B; Dąbrowski M; Werys K; Mazurkiewicz Ł; Kożuch K; Polańska-Skrzypczyk M; Petryka-Mazurkiewicz J; Klisiewicz A; Bilińska ZT; Grzybowski J; Witkowski A; Marczak M
    J Cardiovasc Magn Reson; 2017 Dec; 19(1):105. PubMed ID: 29268761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helical distribution of hypertrophy in patients with hypertrophic cardiomyopathy: prevalence and clinical implications.
    Viliani D; Pozo E; Aguirre N; Cecconi A; Olivera MJ; Caballero P; Jiménez-Borreguero LJ; Alfonso F
    Int J Cardiovasc Imaging; 2017 Nov; 33(11):1771-1780. PubMed ID: 28536896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy.
    Rosmini S; Biagini E; O'Mahony C; Bulluck H; Ruozi N; Lopes LR; Guttmann O; Reant P; Quarta CC; Pantazis A; Tome-Esteban M; Mckenna WJ; Rapezzi C; Elliott PM
    Heart; 2017 Feb; 103(4):300-306. PubMed ID: 27798053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modes of death and clinical outcomes in adult patients with hypertrophic cardiomyopathy in Thailand.
    Songsirisuk N; Kittipibul V; Methachittiphan N; Charoenattasil V; Zungsontiporn N; Spanuchart I; Buppajarntham S; Mankongpaisarnrung C; Satitthummanid S; Srimahachota S; Chattranukulchai P; Boonyaratavej Songmuang S; Puwanant S
    BMC Cardiovasc Disord; 2019 Jan; 19(1):1. PubMed ID: 30606129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the association between the presence of fragmented QRS and the predicted risk score of sudden cardiac death at 5 years in patients with hypertrophic cardiomyopathy.
    Özyılmaz S; Akgül Ö; Uyarel H; Pusuroğlu H; Karayakalı M; Gül M; Çetin M; Satılmışoğlu H; Yıldırım A; Bakır İ
    Anatol J Cardiol; 2017 Jul; 18(1):54-61. PubMed ID: 28559533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise echocardiography in asymptomatic HCM: exercise capacity, and not LV outflow tract gradient predicts long-term outcomes.
    Desai MY; Bhonsale A; Patel P; Naji P; Smedira NG; Thamilarasan M; Lytle BW; Lever HM
    JACC Cardiovasc Imaging; 2014 Jan; 7(1):26-36. PubMed ID: 24290569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the new risk prediction model (HCM Risk-SCD) and classic risk factors for sudden death in patients with hypertrophic cardiomyopathy and defibrillator.
    Ruiz-Salas A; García-Pinilla JM; Cabrera-Bueno F; Fernández-Pastor J; Peña-Hernández J; Medina-Palomo C; Barrera-Cordero A; De Teresa E; Alzueta J
    Europace; 2016 May; 18(5):773-7. PubMed ID: 25855675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of mitral L-wave in patients with hypertrophic cardiomyopathy without risk factors for sudden cardiac death.
    Sugiura Y; Morimoto R; Aoki S; Yamaguchi S; Haga T; Kuwayama T; Yokoi T; Hiraiwa H; Kondo T; Watanabe N; Kano N; Fukaya K; Sawamura A; Okumura T; Murohara T
    Heart Vessels; 2019 Dec; 34(12):2002-2010. PubMed ID: 31152200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related sex differences in the outcomes of patients with hypertrophic cardiomyopathy.
    Lee HJ; Kim HK; Lee SC; Ommen SR; Kim J; Park JB; Choi YJ; Lee SP; Chang SA; Kim YJ
    PLoS One; 2022; 17(2):e0264580. PubMed ID: 35213653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.